NIH (including help desks) will be closed Monday, October 10, 2016 (Columbus Day). If a grant application due date falls on this federal holiday, the application deadline is automatically extended to the next business day.
In a separate post today, we provide an overview of the various reforms the NIH is leading to enhance our stewardship of clinical trials. In this post we’d like to focus a bit more on our efforts to broadly disseminate clinical trial availability and results information.
Timely dissemination of clinical trial results information has been a problem, one that has been documented more than once, and that appears to apply to NIH- as well as non-NIH funded trials. To realize the benefits of a clinical trial, the findings must be available to the public as soon as possible after the trial has concluded. This is not only responsible use of taxpayer dollars for publicly funded trials, but also fulfills our responsibility to the individuals who volunteered in these studies with an understanding that their participation would contribute to advancing medical knowledge. Today, NIH announced a new policy that will complement a new federal regulation, referred to here as the Final Rule, also released today, to improve the accessibility of information on clinical trial availability and on the outcomes and results of completed trials.
As you likely know, to carry out the laws passed by Congress, federal agencies issue regulations that govern the activities of the agency and the applicable community. The “Final Rule” announced today by the U.S. Department of Health and Human Services is … Continue reading
NIH is the largest public funder of clinical trials in the United States. As stewards of this research enterprise, we have been actively listening and discussing how to overcome hurdles and shortcomings that we, and others in the research community, have identified. If you’ve been following the conversation, you’ll know that NIH already has implemented some key reforms to enhance clinical trial stewardship. Today, in a Viewpoint Essay published in the Journal of the American Medical Association (JAMA), we provide an overview of how these reforms, and new initiatives, fit in to the broader picture of building a better clinical trial enterprise through better stewardship, accountability, and transparency.
Figure 1 illustrates the clinical trial “lifespan”, and key opportunities for improving the quality and efficiency of clinical trials – opportunities that translate into more innovative and robust clinical trial design, and accelerated discoveries that will advance human health. NIH is leading a multi-faceted effort that addresses shortcomings and challenges throughout this lifespan, including the application and award process; the scientific review of trial applications; post-award management and oversight; sharing of trial data; and dissemination of research results information to the public. …. Continue reading
In previous blogs, we talked about citation measures as one metric for scientific productivity. Raw citation counts are inherently problematic – different fields cite at different rates, and citation counts rise and fall in the months to years after a publication appears. Therefore, a number of bibliometric scholars have focused on developing methods that measure citation impact while also accounting for field of study and time of publication. We are pleased to report that on September 6, PLoS Biology published a paper from our NIH colleagues in the Office of Portfolio Analysis on “The Relative Citation Ratio: A New Metric that Uses Citation Rates to Measure Influence at the Article Level.” Before we delve into the details and look at some real data, …. Continue reading
As we turn the corner toward the end of the fiscal year, we’d like to remind research institution officials to review whether your awarded grants are accurately assigned to the correct department /school within eRA Commons. This ensures that the grants are reported correctly in tools like RePORT for year-end reporting, and displayed under the right division/school in eRA Commons. On October 13, data for the government’s fiscal year will be frozen, ….. Continue reading
Principal investigators with an Internet Assisted Review (IAR) role — i.e. current and former reviewers — can check if they are eligible for continuous submission of their applications (being allowed extra time to submit and bypassing standard due dates) by going to their Personal Profile in eRA Commons …. Continue reading
Are you a Signing Official (SO) planning to withdraw your grant application? Instead of contacting the NIH Division of Receipt and Referral (DRR) directly, starting on Thursday, Sept. 8, you will be able to request the withdrawal electronically in eRA Commons. …. Continue reading
The pursuit of academic research career can be a challenge, especially when faced with high levels of student loan debt. The escalating costs of advanced education and training are forcing some scientists to abandon their research careers for higher-paying private industry or private practice careers. In exchange for a commitment to conduct biomedical or behavioral research, the NIH will repay up to $70,000 of student loan debt (over two years) per two-year contract through the NIH Loan Repayment Programs (LRPs).
If you are a qualified health professional who agrees to engage in NIH mission-relevant research for at least 20 hours per week at a nonprofit institution, you may be eligible to apply to the one of the five extramural LRPs: ….. Continue reading
This month, NIH published the projected fiscal year 2017 stipend guidelines for postdoctoral trainees and fellows supported by National Research Service Awards (NRSAs). For NRSA-supported postdocs with less than one year’s experience, the stipend level will increase to $47,484. In keeping with the recommendation of the Biomedical Research Workforce Working Group of the NIH Advisory Committee to the Director, stipend levels then increase dependent on years of postdoctoral experience. …. Continue reading
Beginning with the January 25, 2017 application due date, NIH will change what post-submission materials are allowable, and will eliminate most appendix materials currently allowed in applications. …. Continue reading